Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

New steroids were effective in blocking male hormone receptors in hamster prostates.

AHR ligands could treat inflammatory skin diseases.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Targeting the Smoothened receptor shows promise for treating certain cancers.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

HNG helps hair grow by keeping hair in the growth phase longer.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

The hydrogel with a 1:3 ratio of hydroxyethyl cellulose to hyaluronic acid is effective for delivering drugs through the skin to treat acne.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.